BioGeometry

📍 Beijing, China👥 10 employees💰 Last funded Nov 2024
Biotechnology Research🌐 biogeom.com
Website LinkedIn
BioGeometry is an AI-driven biotech dedicated to developing next-generation, programmable protein medicines. We aim to solve the high cost, long lead time, low success rate problems for traditional macromolecular theraputics through the combination of geometric deep learning, structural biology, immunology, and synthetic biology. We enjoy talents from renowned pharmaceutical companies, top-tier AI and bio labs worldwide.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
China
1
Frequently asked questions
Who invested in BioGeometry?
BioGeometry has 1 investors on record on gritt.io.
When did BioGeometry last raise funding?
The most recent investment in BioGeometry recorded on gritt.io was in November 2024.
What industry is BioGeometry in?
BioGeometry operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is BioGeometry based?
BioGeometry is headquartered in Beijing, China.